$2.07 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 81 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CHRS | Exit | COHERUS BIOSCIENCES | $0 | – | -15,940 | -100.0% | -0.02% | – |
| CBM | Exit | CAMBREX CORP | $0 | – | -25,231 | -100.0% | -0.05% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -61,234 | -100.0% | -0.06% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -93,183 | -100.0% | -0.07% | – |
| JAZZ | Exit | JAZZ PHARMA PLC | $0 | – | -13,550 | -100.0% | -0.08% | – |
| ENDP | Exit | ENDO INTL PLCshares | $0 | – | -31,062 | -100.0% | -0.08% | – |
| EGRX | Exit | EAGLE PHARMACEUTIC | $0 | – | -21,899 | -100.0% | -0.08% | – |
| IPXL | Exit | IMPAX LABS INC | $0 | – | -47,031 | -100.0% | -0.09% | – |
| MCK | Exit | MCKESSON CORP | $0 | – | -10,401 | -100.0% | -0.09% | – |
| ALKS | Exit | ALKERMES PLCshares | $0 | – | -25,895 | -100.0% | -0.09% | – |
| Exit | REGENXBIO INC | $0 | – | -156,741 | -100.0% | -0.13% | – | |
| CMRX | Exit | CHIMERIX INC | $0 | – | -550,100 | -100.0% | -0.21% | – |
| CI | Exit | CIGNA CORP | $0 | – | -57,104 | -100.0% | -0.36% | – |
| HTWR | Exit | HEARTWARE INTL INC | $0 | – | -204,008 | -100.0% | -0.44% | – |
| UTHR | Exit | UNITED THERAPEUTICS | $0 | – | -195,280 | -100.0% | -1.30% | – |
| HALO | Exit | HALOZYME THERAPEUTIC | $0 | – | -2,075,796 | -100.0% | -1.53% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -1,275,775 | -100.0% | -2.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.